Publication | Closed Access

Endothelial-monocyte-activating polypeptide II increases blood–tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins

Endothelial Cell PathobiologyAngiogenesisCell AdhesionImmunologyEndothelial DysfunctionCancer Cell BiologyBlood–tumor Barrier PermeabilityCell-matrix InteractionVascular BiologyEndothelial-monocyte-activating Polypeptide IiMedicineCell BiologyCell SignalingTight JunctionTumor BiologyExtracellular Matrix